A critical review of T cell targeting immunotherapy in pancreatic cancer: only a hypothesis or a real hope for the patients?

Author： Glenjen Nils Bruserud Øystein

Publisher： Informa Healthcare

ISSN： 1471-2598

Source： Expert Opinion on Biological Therapy, Vol.2, Iss.7, 2002-10, pp. : 693-701

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Biological treatment in acute myelogenous leukaemia: how should T-cell targeting immunotherapy be combined with intensive chemotherapy?

By Wendelboe Øystein Bruserud Øystein

Expert Opinion on Biological Therapy, Vol. 1, Iss. 6, 2001-11 ,pp. : 1005-1016

Informa Healthcare

Access to resources Recommend Favorite

Adoptive T cell immunotherapy for cytomegalovirus

By Peggs Karl S

Expert Opinion on Biological Therapy, Vol. 9, Iss. 6, 2009-06 ,pp. : 725-736

Informa Healthcare

Access to resources Recommend Favorite

Immunoregulatory T cells in cancer immunotherapy

By Morse Michael A Clay Timothy M Mosca Paul Lyerly H Kim

Expert Opinion on Biological Therapy, Vol. 2, Iss. 8, 2002-12 ,pp. : 827-834

Informa Healthcare

Access to resources Recommend Favorite

Dendritic cell immunotherapy for breast cancer

By Pinzon-Charry Alberto Schmidt Chris López José Alejandro

Expert Opinion on Biological Therapy, Vol. 6, Iss. 6, 2006-06 ,pp. : 591-604

Informa Healthcare

Access to resources Recommend Favorite

Sipuleucel-T and immunotherapy in the treatment of prostate cancer

By Dawson Nancy A Roesch Erin E

Expert Opinion on Biological Therapy, Vol. 14, Iss. 5, 2014-05 ,pp. : 709-719

Informa Healthcare

Access to resources Recommend Favorite